Summary
A new blood test is being trialed in the UK to improve Alzheimer's disease diagnosis. This test aims to detect specific proteins in the brain more accurately than current methods. Scientists hope it will lead to quicker diagnoses and better treatment options for patients.
Key Facts
- A blood test for Alzheimer's is being tested on over 1,000 people in the UK.
- The test looks for biomarkers, which are signs in the body, of proteins linked to Alzheimer's.
- Scientists believe the test could increase diagnosis accuracy from 70% to over 90%.
- The trial is conducted at University College London and involves 20 memory clinics.
- Alzheimer's is the most common type of dementia, caused by proteins amyloid and tau building up in the brain.
- The trial involves recruiting participants and testing whether quicker results improve patient care.
- If successful, the test could become a standard part of Alzheimer's diagnosis.
- The study is supported by Alzheimer's Research UK and other organizations, with funding from the People's Postcode Lottery.
